Searchable abstracts of presentations at key conferences in endocrinology

ea0036P74 | (1) | BSPED2014

Impaired insulin and IGF2 signalling in the primordial growth disorder 3-M syndrome

Kallampallil Jins , Acimovic Ksenija , Hanson Daniel , Whatmore Andrew , Clayton Peter

Introduction: 3-M syndrome is associated with mutations in CUL7, OBSL1 and CCDC8 with the three proteins interacting within a novel growth pathway. The impact of this pathway on cellular growth has not been fully defined. We have shown that i) GH and IGF1 signalling are altered; ii) IGF2 expression is reduced and iii) expression of insulin receptor isoforms are altered in 3-M fibroblasts.Aim: To characterise the activa...

ea0035n4 | (1) | ECE2014

Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms

Dwyer Andrew , Tiemensma Jitske , Quinton Richard , Morin Diane , Pitteloud Nelly

Background: For chronic diseases, adherence to treatment remains a major clinical challenge. For men with long-term hypogonadism, there is scant data regarding adherence to treatment. Congenital hypogonadotropic hypogonadism (CHH) is a rare, genetic, endocrine disorder characterized by incomplete/absent puberty and infertility. Little is known about adherence in this patient population or the psychosocial implications of living with this rare disorder. Therefore, we aimed to e...

ea0035p39 | Adrenal cortex | ECE2014

Behavioural research into adrenal insufficiency (AI) patients' perceptions of AI medication, symptoms and adherence: results of a multi-country, European online survey

Martello Andrew , Cotterell Holly , Tayarani-Binazir Kayhan , Seebeck Natalie

Introduction: Previous qualitative studies have explored perceptions of medication among patients with adrenal insufficiency (AI) as possible determinants of treatment satisfaction. This study is the first to quantify patients’ perceptions of AI medication (necessity beliefs and concerns) and their satisfaction with information and to assess whether medication beliefs and satisfaction are related to adherence.Methods: Validated questionnaires were u...

ea0060p08 | (1) | UKINETS2018

Periodic endoscopic surveillance in patients with low risk type I gastric neuroendocrine tumours (gNETs) also detects associated gastric adenocarcinoma in a subset of patients

Hu Haiyi , Exarchou Klaire , Moore Andrew , Pritchard D Mark

Background: People who have autoimmune atrophic gastritis commonly develop type 1 gNETs, but are also at increased risk of developing gastric adenocarcinoma. Type I gNET patients usually have multiple gastric polyps and have an excellent prognosis when the polyps measure.Method: Retrospective audit of type I gNET patients managed within Liverpool ENETS Centre of Excellence 2004–2018.Results: 86 patients (median age 67 years, 5...

ea0034p98 | Clinical practice/governance and case reports | SFEBES2014

Outcomes following pituitary surgery: a single centre audit

Manolopoulos Konstantinos , Bates Andrew S , Shad Amjad , Rahim Assad

Introduction: Pituitary surgery is associated with post-operative complications including hypopituitarism and visual field defects. In order to ensure that our surgical outcomes were comparable with other centres, we audited the outcome of a cohort of patients referred for surgery at a single centre.Methods: A retrospective audit of 27 consecutive patients diagnosed with pituitary adenoma at Heartlands Hospital Birmingham, who underwent trans-sphenoidal ...

ea0034p140 | Clinical practice/governance and case reports | SFEBES2014

Is levothyroxine availability enhanced by grapes?

Khan Ishrat , Aldridge Andrew , Ahmed Ruhina , Onyebuchi O E

Introduction: Patients with hypothyroidism are routinely advised to take levothyroxine without food or beverages but the pharmacokinetic effect of many common foods are unknown. We describe a patient with an unusually high levothyroxine requirement who only achieved adequate replacement by taking grapes along with levothyroxine. Through a cycle of challenge, withdrawal, and-re-challenge, we were able to demonstrate that levothyroxine availability was enhanced by grapes in this...

ea0034p163 | Growth and development | SFEBES2014

C-type natriuretic peptide regulates growth and pituitary development in the zebrafish (Danio rerio)

Lessey Andrew , Mirczuk Samantha , McGonnell Imelda , Fowkes Robert

C-type natriuretic peptide (CNP), the predominant natriuretic peptide in the pituitary, is associated with neuroendocrine development and function. Our previous studies show that genes encoding CNP (nppc2, cnp3, nppc4, and nppcl) are expressed during pituitary development in humans and zebrafish (Danio rerio), however a precise role for CNP in the pituitary has yet to be elucidated. Using the versatile zebrafish, we explored in ...

ea0034p198 | Nursing practise | SFEBES2014

Emergency hydrocortisone kits: assessment of knowledge and skills of patients and family

Shepherd Lisa , Ulnasah Sadaf , Rahim Asad , Shakher Jayadave , Bates Andrew

It is recommended that patients with adrenal insufficiency should be in possession of an emergency hydrocortisone kit and have sufficient knowledge and skills to administer it. Historically, in our unit patient education was dependent on referral from Doctors to endocrine specialist nurses (ESN’s). This study sought to assess if patients owned a kit and if patients and family were competent to administer the injection if required.A ‘snapshot&#1...

ea0034p246 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Impact of chronic heart failure on adipose tissue functional plasticity: a role for fatty acids?

Yale Andrew , Cobb Malcolm , Lyon Alexander , Mostyn Alison

Chronic heart failure (HF) is a major cause of morbidity and mortality in humans and domestic animals. HF is characterised by chronic inflammation and functional changes in non-cardiovascular tissues; obesity is also associated with low level chronic inflammation, with adipose tissue (AT) exhibiting infiltration of macrophages and alterations in fatty acid (FA) profiles. The aim of this project was to investigate expression of regulators of lipid metabolism and inflammation an...

ea0034p295 | Pituitary | SFEBES2014

Can 0900 h serum cortisol levels be used to predict patient's response to the insulin tolerance test?

Kyriakakis Nikolaos , Appleton Elizabeth , Andrew Julie , Murray Robert

Aim: The insulin tolerance test (ITT) is considered the gold standard test in assessing the integrity of the hypothalamic–pituitary–adrenal (HPA) axis. The aim of this study is to evaluate if the 0900 h cortisol levels can be predictive of the patient’s response to hypoglycaemia, minimizing the use of the ITT as it is labour, intensive and unpleasant for the patient.Methods: This is a retrospective study of 110 ITTs performed at the Endocr...